LadRx Corporation Navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • NeuroDegenerative
    • Arimoclomol
  • Oncology
    • Aldoxorubicin
    • LADR™
  • Investors
    • Overview
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Corporate Governance
    • Presentations
    • Email Alerts
    • Information Request
    • Online Investor Kit
  • News & Events
    • Press Releases
    • Virtual Event
  • Contact
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • NeuroDegenerative
    • Arimoclomol
  • Oncology
    • Aldoxorubicin
    • LADR™
  • Investors
    • Overview
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Corporate Governance
    • Presentations
    • Email Alerts
    • Information Request
    • Online Investor Kit
  • News & Events
    • Press Releases
    • Virtual Event
  • Contact

Online Investor Kit

Home Investor Relations Online Investor Kit

Online Investor Kit

You can quickly assemble your own Investor Kit by selecting and printing from the following documents. To order printed materials, or request additional investor-related information, complete an information request.

  • Annual Report: 2022 (PDF)
  • Form 10-K: 2021 (PDF)
  • Investor Presentation: November 2022 (PDF)
  • Definitive Proxy Statement: June 2022 (PDF)
  • 10-Q Second Quarter 2022 (PDF)

You may also find news of interest to investors on our News Releases page.

Need Information?

310-826-5648 info@ladrxcorp.com

Investor Relations

  • Investor Relations
  • Stock Information
  • Investor FAQs
  • Analyst Coverage
  • Annual Reports
  • SEC Filings
  • Corporate Governance
  • Presentations
  • Email Alerts
  • Information Request
  • Online Investor Kit
  • About
  • NeuroDegenerative
  • Oncology
  • Investors
  • News & Events
  • Contact

© 2022 LadRx Corporation